Your browser doesn't support javascript.
loading
[Durable remission attained by long-term brentuximab vedotin administration in a relapsed post-allogeneic bone marrow transplant Hodgkin lymphoma patient].
Ono, Yuichiro; Hiramoto, Nobuhiro; Yoshioka, Satoshi; Yabushita, Tomohiro; Koba, Yusuke; Tabata, Sumie; Imai, Yukihiro; Ishikawa, Takayuki.
  • Ono Y; Department of Hematology, Kobe City Medical Center General Hospital.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital.
  • Yoshioka S; Department of Hematology, Kobe City Medical Center General Hospital.
  • Yabushita T; Department of Hematology, Kobe City Medical Center General Hospital.
  • Koba Y; Department of Hematology, Hyogo Prefectural Amagasaki Hospital.
  • Tabata S; Department of Hematology, Kitano Hospital, The Tazuke Kofukai Medical Research Institute.
  • Imai Y; Department of Clinical Pathology, Kobe City Medical Center General Hospital.
  • Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital.
Rinsho Ketsueki ; 58(12): 2397-2401, 2017.
Article en Ja | MEDLINE | ID: mdl-29332873
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Male Idioma: Ja Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Male Idioma: Ja Año: 2017 Tipo del documento: Article